PTC Therapeutics | PTCT - 销售收入



金融业
股票价格
USD
资产
USD 3.25B
现金及等价物
USD 1.05B
销售成本
USD 39.61M
流动资产
USD 2.62B
流动负债
USD 771.07M
债务
USD 286.94M
EBIT
USD 45.89M
EBITDA
USD 61.98M
员工
939
EPS每股收益
USD 0.92
股本和储备
USD -165.36M
销售毛利
USD 232.94M
债务利息支出
USD 3.25B
贷款资金
USD 535.52M
市值
USD 5.47B
净收入
USD -2.81M
营业费用
USD 226.67M
营业利润
USD 45.89M
普通股股本
USD 82.88M
PE价格收益
8.76
税前利润
USD -2.46M
销售收入
USD 361M
销售和管理费用
USD 73.89M
股票
USD 91.35M
贸易债权人
USD 40.45M
应收帐款人
USD 219.92M


销售 更改 日
Acadia Pharmaceuticals USD 307.96M 39.9M 2026-06
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Amgen USD 10.1B 1.48B 2026-06
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Biogen USD 2.74B 490M 2026-06
BioMarin Pharmaceutical USD 990M 224M 2026-06
Cytokinetics USD 28.6M 9.25M 2026-06
Daiichi Sankyo JPY 574.74B 12.26B 2026-06
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Gilead Sciences USD 7.8B 800M 2026-06
Incyte USD 1.67B 400M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Ironwood Pharmaceuticals USD 113.04M 6.53M 2026-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Novartis USD 14.41B 1.3B 2026-06
Pfizer USD 15.03B 530M 2026-06
PTC Therapeutics USD 361M 88M 2026-06
Puma Biotechnology USD 80.54M 33.46M 2024-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
TG Therapeutics USD 240.34M 45.54M 2026-06
Ultragenyx Pharmaceutical USD 214M 78M 2026-06
Vertex Pharmaceuticals USD 3.33B 340M 2026-06
Xencor USD 51.22M 46.71M 2026-06